Molecular Mechanism and Therapeutic Targeting of Necrosis, Apoptosis, Pyroptosis, and Autophagy in Cardiovascular Disease
Cell death is a fundamental biological process that occurs in various tissues and organs, playing a critical role in maintaining cellular morphology and function, as well as eliminating abnormal cells. The heart, being the most vital organ in the body, is particularly susceptible to the effects of cell death. This review focuses on the molecular mechanisms of different cell death modes—necrosis, apoptosis, pyroptosis, and autophagy—and their implications in cardiovascular diseases (CVDs). Understanding these mechanisms is crucial for developing therapeutic strategies to mitigate cardiac dysfunction and improve patient outcomes.
Introduction
Cell death is a pivotal event that can lead to organ dysfunction and severe health consequences. While some forms of cell death are physiological and beneficial, others can result in pathological conditions. The primary modes of cell death include apoptosis, necrosis, pyroptosis, and autophagy. These modes are interconnected and can occur simultaneously in response to cellular stress. For instance, reactive oxygen species (ROS) and calcium (Ca2+) can regulate both autophagy and apoptosis. Cardiovascular diseases, which have the highest incidence and mortality rates globally, are often associated with myocardial cell death. This review explores the mechanisms of these cell death modes and their impact on the heart, as well as potential therapeutic interventions.
Mechanisms of Cell Death Modes
Necrosis
Necrosis, traditionally viewed as an unregulated and accidental form of cell death, is now understood to be an active, regulated process. It is characterized by the destruction of organelles and cell membranes, often accompanied by inflammatory reactions. Necrosis can be triggered by various stimuli, including ROS, b1-adrenergic receptor agonists, angiotensin II, and pro-inflammatory cytokines. The mitochondrial pathway of necrosis involves the mitochondrial permeability transition pore (MPTP), which, when opened, leads to mitochondrial depolarization, cessation of ATP production, and cell membrane rupture. The death receptor pathway of necrosis is mediated by receptor-interacting proteins (RIPs) and mixed-lineage kinase domain-like protein (MLKL), which disrupt cell membrane integrity and induce necrosis.
Apoptosis
Apoptosis is a programmed cell death process involving changes in organelles, cell membranes, and the nucleus. It is characterized by chromatin condensation, nuclear fragmentation, cell contraction, and the formation of apoptotic bodies. Apoptosis can be triggered via intrinsic (mitochondrial) or extrinsic (death receptor) pathways. The intrinsic pathway is activated by stimuli such as growth factor deprivation, hypoxia, oxidative stress, or DNA damage, leading to the activation of pro-apoptotic proteins like Bax and Bak. The extrinsic pathway involves the binding of Fas ligand or TNF-a to their receptors, activating caspase-8 and subsequently caspase-3, which execute the apoptotic program.
Pyroptosis
Pyroptosis is a form of programmed cell death that shares similarities with apoptosis but is distinct in its reliance on caspase-1. It is characterized by cell membrane pore formation, cellular content outflow, and inflammation. Pyroptosis can occur via classical (caspase-1-dependent) or non-classical (caspase-4/5/11-dependent) pathways. The classical pathway involves the activation of inflammasomes like NLRP3 and AIM2, which activate caspase-1, leading to the cleavage of Gasdermin D (GSDMD) and the release of inflammatory cytokines like IL-1b and IL-18. The non-classical pathway is activated by lipopolysaccharides (LPS) and involves caspase-4/5/11, which also cleave GSDMD to induce pyroptosis.
Autophagy
Autophagy is a cellular degradation process mediated by double-membrane autophagosomes, which degrade malformed proteins and defective organelles. It is a survival mechanism under poor conditions and is regulated by autophagy-related proteins (ATGs) like ATG5 and Beclin-1. Autophagy involves the formation of autophagosomes, which fuse with lysosomes to degrade their contents. While autophagy is generally protective, excessive autophagy can lead to cell death. In the heart, autophagy plays a dual role, with moderate autophagy being protective and excessive autophagy contributing to cardiac dysfunction.
Cardiac Dysfunction Caused by Multiple Modes of Cell Death
Necrosis
Necrosis, once considered an unregulated process, is now recognized as a regulated form of cell death that contributes to cardiac dysfunction. Myocardial cell necrosis, particularly in response to oxidative stress and ischemia-reperfusion (IR), is a key mechanism in heart failure. The MPTP, regulated by cyclophilin D (CypD), plays a central role in necrosis. Inhibition of CypD has been shown to reduce myocardial injury following IR, highlighting the potential for therapeutic intervention.
Apoptosis
Apoptosis is relatively rare in the normal myocardium but becomes significant in pathological conditions like myocardial infarction and heart failure. The ROS-ASK1-JNK pathway is a critical mediator of cardiomyocyte apoptosis. Inhibition of ASK1 has been shown to protect against oxidative stress-induced apoptosis, suggesting a potential therapeutic target for heart failure.
Pyroptosis
Pyroptosis is implicated in various cardiovascular diseases, including atherosclerosis and diabetic cardiomyopathy. The NLRP3 inflammasome, activated by oxidized low-density lipoprotein (oxLDL) and high glucose, plays a central role in pyroptosis. Inhibition of NLRP3 or its downstream effectors like caspase-1 and IL-1b has been shown to mitigate cardiac dysfunction, highlighting the therapeutic potential of targeting pyroptosis.
Autophagy
Autophagy is observed in heart failure caused by various conditions, including dilated cardiomyopathy and ischemic heart disease. The role of autophagy in the heart is complex, with moderate autophagy being protective and excessive autophagy contributing to cardiac dysfunction. Key regulators of autophagy, such as Beclin-1 and ATG5, have been shown to influence cardiomyocyte survival. Enhancing autophagy has been proposed as a strategy to protect against myocardial injury.
Recent Advances in the Treatment of Heart Disease Based on Various Cell Death Methods
Necrosis
Therapeutic strategies targeting necrosis focus on inhibiting the MPTP and death receptor pathways. Inhibitors of RIP1 and MLKL have shown promise in reducing myocardial necrosis and improving cardiac function. For example, Nec-1, an inhibitor of RIP1, has been shown to reduce inflammation and improve ejection fraction in ischemic heart disease.
Apoptosis
Targeting the apoptosis pathway, particularly the ASK1-p38 pathway, has shown potential in preventing cardiomyocyte apoptosis and improving heart function. Trimetazidine (TMZ), a drug that reduces intracellular acidosis and apoptosis, has been shown to protect myocardial function in patients with heart failure.
Pyroptosis
Inhibiting the pyroptosis pathway, particularly the NLRP3 inflammasome and its downstream effectors, has emerged as a promising therapeutic strategy. Resveratrol, a natural polyphenol, has been shown to protect against heart injury by inhibiting NLRP3 activation. Similarly, low doses of erucic acid have been shown to reduce NLRP3 activation and improve cardiac function.
Autophagy
Enhancing autophagy has been proposed as a strategy to protect against myocardial injury. Melatonin, an antioxidant, has been shown to enhance autophagy and reduce cardiomyocyte injury. Similarly, the deletion of ATG5, a key regulator of autophagy, has been shown to exacerbate cardiac dysfunction, highlighting the importance of autophagy in maintaining cardiac health.
Conclusion and Perspectives
Cell death plays a critical role in the development and progression of cardiovascular diseases. Understanding the mechanisms of necrosis, apoptosis, pyroptosis, and autophagy is essential for developing targeted therapies to mitigate cardiac dysfunction. While significant progress has been made in understanding these mechanisms, many questions remain. For instance, the regulation of necrosis and its diversity among different cell types require further investigation. Additionally, the interplay between different modes of cell death and their impact on cardiac function needs to be elucidated. Future research should focus on translating these findings into clinical applications to improve patient outcomes.
doi.org/10.1097/CM9.0000000000001772
Was this helpful?
0 / 0